JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

B1786 Meclizine 2HCl
3 Citation

Summary: Histamine H1 receptor antagonist
B1789 Mexiletine HCl

Target: sodium channel

Summary: Sodium channel inhibitor

≥10.2 mg/mL
B2270 Ouabain

Summary: selective Na+/K+-ATPase inhibitor

≥72.9 mg/mL
B1523 PF-573228
4 Citation

Summary: ATP-competitive FAK inhibitor

insoluble in EtOH; insoluble in H2O; ≥166.6 mg/mL
B2022 Ronidazole

Summary: antiprotozoal agent

insoluble in H2O; insoluble in EtOH; ≥6.5 mg/mL
B2023 Ropivacaine HCl

Summary: Sodium channel inhibitor

≥10.1 mg/mL
B2057 Trimethoprim
1 Citation

Summary: bacteriostatic antibiotic

insoluble in EtOH; insoluble in H2O; ≥28.93 mg/mL
B2040 Sulfamethoxazole

Summary: sulfonamide bacteriostatic antibiotic

insoluble in H2O; ≥7.75 mg/mL
B1343 Phenoxybenzamine HCl

Summary: Adrenergic receptor antagonist

insoluble in H2O; ≥17.02 mg/mL
B2281 Propafenone HCl
1 Citation

Summary: classic anti-arrhythmic medication

insoluble in H2O; ≥18.6 mg/mL